MABVAX THERAPEUTICS HLDGS INC
MBVX
MBVX was delisted on the 10th of July, 2018.
2 hedge funds and large institutions have $15K invested in MABVAX THERAPEUTICS HLDGS INC in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 13 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
86% less funds holding
Funds holding: 14 → 2 (-12)
92% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 13
99% less capital invested
Capital invested by funds: $1.13M → $15K (-$1.12M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$21.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$876K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$108K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$65K |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$24K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$23K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAM
1
Panagora Asset Management
Boston,
Massachusetts
| $11K | +$21.8K | +26,382 | New |
|
|
BCM
2
Biomark Capital Management
Greenwich,
Connecticut
| $4K | – | – | – |
|
|
3
Cambridge Investment Research Advisors
Fairfield,
Iowa
| – | -$876K | -1,030,310 | Closed |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| – | -$108K | -126,592 | Closed |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$65K | -75,904 | Closed |
|
|
6
Commonwealth Equity Services
Waltham,
Massachusetts
| – | -$24K | -27,865 | Closed |
|
|
7
Citadel Advisors
Miami,
Florida
| – | -$23K | -27,385 | Closed |
|
|
VF
8
Virtu Financial
New York
| – | -$11K | -12,783 | Closed |
|
9
UBS Group
Zurich,
Switzerland
| – | -$10K | -11,889 | Closed |
|
10
Bank of America
Charlotte,
North Carolina
| – | -$6K | -6,664 | Closed |
|
11
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$3K | -2,999 | Closed |
|
MBVX Hedge Fund Activity: Q3 2018 in Review
2 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in MABVAX THERAPEUTICS HLDGS INC (MBVX) for Q3 2018, worth a combined $15K — down 99% from $1.13M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of MBVX and 1 opened new positions — a net loss of 12 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Panagora Asset Management, opening a new position worth an estimated $21.8K. The largest seller was Cambridge Investment Research Advisors, exiting entirely with an estimated $876K sold.
- 2 institutional investors held MABVAX THERAPEUTICS HLDGS INC (MBVX) as of Q3 2018, down from 14 in Q2 2018.
- Funds reported $15K of MABVAX THERAPEUTICS HLDGS INC stock for Q3 2018, down 99% quarter-over-quarter.
- 1 fund opened new MABVAX THERAPEUTICS HLDGS INC positions in Q3 2018 and 13 closed out, a net change of -12 holders.
- The largest MABVAX THERAPEUTICS HLDGS INC buyer in Q3 2018 was Panagora Asset Management, an estimated $21.8K added.
- The largest MABVAX THERAPEUTICS HLDGS INC seller in Q3 2018 was Cambridge Investment Research Advisors, an estimated $876K sold.
Based on aggregated 13F filings for Q3 2018.